This site is intended for healthcare professionals only
LoginRegister
SEC Approves Serums Salk Polio Vaccine for Commercial Use, Recommends Phase I Trial for 21-valent Pneumococcal VaccineRevise Phase II/III CT protocol of Yellow Fever Vaccine Live: CDSCO Panel Tells Serum Institute of...
Health Ministry gets Porter Prize 2023 for COVID-19 managementHealth Ministry gets Porter Prize 2023 for COVID-19 management
Pfizers Abrocitinib Phase III Data Accepted by CDSCO Expert CommitteePfizer, BioNTech submit application to USFDA for emergency use nod of Omicron BA.4/BA.5-adapted...
Respiratory Syncytial virus vaccine effective in older adults, finds NEJM studyRespiratory Syncytial virus vaccine effective in older adults, finds NEJM study
USFDA nod to Padcev plus Keytruda for certain patients with Bladder cancer: Pfizer, Astellas PharmaPfizer RSV vaccine for elderly linked to Guillain-Barre risk, says USFDA
Wockhardt plans to roll out two vaccines within year from UK facility as part of a tie-up with SIIWockhardt plans to roll out two vaccines within year from UK facility as part of a tie-up with SII
USFDA nod to Padcev plus Keytruda for certain patients with Bladder cancer: Pfizer, Astellas PharmaPfizer, BioNTech seek USFDA nod for Omicron BA.4/BA.5-Adapted Bivalent COVID vaccine for ages 12...
USFDA nod to Padcev plus Keytruda for certain patients with Bladder cancer: Pfizer, Astellas PharmaPfizer Respiratory Syncytial Virus Maternal Vaccine candidate gets USFDA priority review
Moderna-Merck gets USFDA Breakthrough Therapy Designation for personalized mRNA cancer vaccine in combination with KEYTRUDA to treat high risk melanomaModerna-Merck gets USFDA Breakthrough Therapy Designation for personalized mRNA cancer vaccine in...
Study finds COVID-19 vaccination linked to fewer cardiac eventsStudy finds COVID-19 vaccination linked to fewer cardiac events
Clinical trials for BioNTech cancer vaccines should start this year in Britain: Ugur SahinClinical trials for BioNTech cancer vaccines should start this year in Britain: Ugur Sahin
Pfizer, Valneva to stop Lyme disease vaccine trial in some patientsPfizer, Valneva to stop Lyme disease vaccine trial in some patients
X